Cytomegalovirus (CMV) in breast milk is transmitted to infants and may be associated with disease especially in preterm infants. We present a preterm twin with postnatally acquired CMV infection and evidence of CMVassociated necrotizing enterocolitis.
INTRODUCTION
Congenital cytomegalovirus (CMV) infection from maternal CMV infection is a well-known cause of perinatal morbidity and mortality. In contrast, postnatal transmission of CMV from mother to baby by breast milk has been less well studied. CMV has been detected in breast milk in 32 to 96% of CMV seropositive mothers and the rate of transmission was 37%. 1 Although CMV has been shown to be present in breast milk and transmissible to infants, severe disease is uncommon in term infants because they are protected by passively acquired maternal antibodies. 2 Premature infants, however, have an immature immune system and are born before the transfer of the majority of protective immunoglobulins, which occurs after 28 weeks. This may make them more susceptible to CMV disease following primary infection. 2 Symptomatic infants are seen in 15 to 48% of very-low-birth-weight (VLBW) infants with CMV infection; these infants suffer substantially, that is, sepsis-like illnesses, respiratory failure, hepatopathy, thrombocytopenia, and neutropenia. 3 We report the transmission of CMV in a VLBW twin due to feeding CMVcontaining breast milk. The signs and symptoms included sepsislike deterioration, liver involvement, thrombocytopenia, and most interestingly, evidence of CMV-associated necrotizing enterocolitis.
CASE REPORT
Twins were born at 29 6 7 weeks of gestation to a 39-year-old third gravida and primipara mother. Twin A had a birth weight of 1490 g (P25-50), a length of 38.5 cm (P25-50), and a head circumference of 28 cm (P25-50). Apgar scores were 6 and 9 at 1 and 5 minutes, respectively. Twin B was 1530 g of weight, 39 cm long, and had a head circumference of 28.5 cm. The spontaneous dichorionic diamniotic twin pregnancy was uneventful. Maternal serologies determined at the 5th week of gestation were rubella IgG 49 U/ml (positive), IgM negative, anti-hepatitis B core negative, anti-hepatitis B surface negative, toxoplasmosis IgG 39 U/ml (positive) and IgM negative. CMV serology determined at the 5th, 13th, and 27th week of gestation were IgG 85, 92, and 94 U/ml (positive), and IgM negative, respectively (AxSYM immunoassay, Abbott Laboratories, IL). There was preterm onset of labor at 29 weeks of gestation and the twins were born by cesarean section after induction of lung maturation with steroids. Twin A had respiratory distress syndrome and received continuous positive airway pressure (CPAP) therapy using nasal prongs during the first day of life. Feeding was started with breast milk at the age of 2 days. At the age of 6 days, he showed clinical deterioration with apneic spells, bradycardia, and a distended abdomen with bloody stools. Laboratory signs of infection were positive and radiograph of abdomen showed pneumatosis intestinalis concordant with the diagnosis of necrotizing enterocolitis (NEC). Gastrointestinal feedings were discontinued and treatment with amoxicillin plus clavulanic acid and gentamicin started. Bacterial cultures of urine and blood were sterile. Feedings were reintroduced in small amounts after 6 days and antibiotics stopped. Twin A, who suffered from NEC, preferentially was given breast milk. His brother additionally received a commercial formula, when mother's breast milk did not suffice for both twins. Twin A received leukocyte-filtered CMV-free blood transfusions four times, the first at 7 days of age. The clinical course of twin B was uneventful.
At the age of 6 weeks, twin A again presented with signs of infection: mottled color of the skin, fever, hepatosplenomegaly, and thrombocytopenia of 17 g/l. Owing to suspicion of bacterial infection, he was treated with amoxicillin and gentamicin until bacterial cultures of blood, urine, and stool proved to be negative. However, CMV was detected in urine using virus isolation in shell vial cultures of MRC-5 fibroblasts followed by identification of CMV early antigene by immunofluorescence (Argène/Biosoft, Varhiles, France). 4 Determination of IgG and IgM antibodies for CMV using enzyme-linked immunosorbant assays were negative at this time (VIDAS immunoassay system, bioMérieux, Marcy-l'Etoile, France). Breast milk of the mother was tested positive for CMV by polymerase chain reaction 5 and, thus, was identified as likely source of infection. The patient was treated symptomatically and received transfusion of platelets because of thrombocytopenia. An ophthalmologic examination excluded CMV chorioretinitis. No CMV was detected in urine of twin B by shell vial culture.
At the age of 10 weeks, twin A presented with vomiting and poor drinking, he was lethargic, the skin color gray, and the abdomen distended. Abdominal radiograph demonstrated distended bowel loops in the left hemiabdomen and a barium enema showed a tight stricture in the middle of the colon transversum as well as a second stricture in the colon ascendens. Laparatomy was performed and strictures excised with a primary anastomosis between colon ascendens and transversum. Pathology findings showed ulcerating and granulating inflammation of the colonic mucosa (Figure 1a) . Immunohistochemical investigations demonstrated CMV in detached endothelial cells (Figure 1b) . Urine was still positive for CMV early antigen, the patient again showed thrombocytopenia of 25 g/l and was given platelet transfusion. The postoperative course was complicated by prolonged enteral feeding reconstitution and persistent hepatosplenomegaly with ascites. He was discharged 7 weeks after surgery thriving on oral feeds, neurologic examination showing no abnormalities.
DISCUSSION
Enterocolitis in the neonate usually presents as NEC resulting from complex interactions between mucosal injury secondary to a variety of factors, including ischemia, luminal substrate, and infection, and poor host-protective mechanisms in response to injury. 6 We demonstrate evidence that enterocolitis is a clinical part of postnatally acquired CMV infection.
Postnatal CMV transmission from mother to preterm infant may be due to breastfeeding. 1 In fact, we demonstrated CMV in breast milk as a possible source of CMV infection. However, the other twin was also fed with breast milk but neither showed signs of infection nor CMV excretion in the urine. Nonbreast milk sources of CMV included excretion from other maternal sites (e.g. urine, cervical secretions), transmission from other people, or transmission by blood. 7 In our patient, blood products were CMV-free and transmission via maternal secretions seems unlikely after cesarean section. Viral load of breast milk as well as the duration of breastfeeding may influence the rate of acquisition of CMV infection.
8 Interestingly, after reinstitution of feeding, the twin with the NEC preferentially was fed with breast milk, whereas the other twin was supplemented with formula due to the small amount of available breast milk.
Our patient showed clinical and radiological evidence of NEC beginning at the 6th day of life. Feedings were discontinued, antibiotics were started and no gastrointestinal perforation occurred. The clinical course was complicated by strictures that required surgical intervention. Surprisingly, instead of a fibroproliferative process, an inflammatory disorder with detection of CMV was described in the removed section of the colon. CMV enteritis in the immunocompromised pediatric and adult patient has been well documented. In newborns, however, there are only a few reports of NEC associated with CMV infection. CMV was detected during acute illness 9 as well as during the proliferative stage of stricture development after NEC. 10, 11 Unfortunately, the route of CMV transmission remained poorly described. Our patient had clinical signs of systemic disease at 6 weeks of life with CMV detection in the urine. Therefore, CMV infection may well contribute to the inflammatory process in the bowel detected at the age of 10 weeks. It remains speculative, whether the initial symptoms of NEC at the age of 6 days were caused by CMV ingested with breast milk. At the age of 6 days, only blood cultures were taken in search of bacterial causes of NEC and breast milk was not screened for CMV at that time. However, the timing of CMV excretion in breast milk has been studied and CMV has been isolated from breast milk as early as 1 day after delivery. 12 Hamprecht et al. 1 showed appearance of viral DNA in milk whey at a median time of 3.5 days. Treatment of CMV infection with ganciclovir was discussed and refused because there were no signs of central nervous system involvement and because of concerns about the side effects of ganciclovir. 13, 14 In conclusion, postnatal CMV infection in preterm infants may present clinically as enterocolitis. Since CMV transmission via breast milk can occur early during postnatal life, CMV may be an infectious cause of NEC.
